Lilly
-
USA
Eli Lilly will file for approval of retatrutide obesity drug in 2027
The Eli Lilly logo is seen at the company’s office in San Diego, California, on November 21, 2025. Mike Blake…
Read More » -
UK
Ozempic-maker Novo Nordisk sues rival Eli Lilly, accusing it of false advertising
Novo Nordisk, the maker of Wegovy and Ozempic, has taken legal action against archrival Eli Lilly, accusing it of false…
Read More » -
USA
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
The Eli Lilly logo is seen at the company’s office in San Diego, California, on November 21, 2025. Mike Blake…
Read More » -
UK
Body found in Wales park identified as missing teenager Lilly Jones
Sign up for our breaking news emails for free real-time breaking news alerts delivered straight to your inbox Sign up…
Read More » -
USA
Eli Lilly, Regeneron in FDA PreCheck manufacturing program
Eli Lilly And Regeneration According to information obtained by CNBC, it is among the first seven companies selected by the…
Read More » -
USA
Lilly, Novo, Pfizer look to new weight loss drugs
Drugmakers are just months away from launching GLP-1 pills and making major changes to the way patients pay for weight-loss…
Read More » -
USA
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits
NEW YORK, June 6 (Reuters) – Drugmaker Eli Lilly presented medical experts on Saturday with trial results showing its “next-generation…
Read More » -
USA
Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo is seen at the company’s office in San Diego, California, USA on November 21, 2025. Mike…
Read More » -
USA
Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
Eli Lilly On Tuesday, it announced plans to buy three companies for about $4 billion in cash as it plans…
Read More » -
USA
Eli Lilly lawsuit says rebate fraud tied to Pentecostal church leaders
Eli Lilly He accused several bishops at a major Pentecostal church of fraud, saying he had uncovered a long-running scheme…
Read More »